TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...
A deeper-than-expected global economic recession is likely to weigh on the demand for air travel. Besides reduced leisure travel as tourists tighten up their discretionary spending, businesses may ...
AM Best has assigned a Financial Strength Rating of B and a Long-Term Issuer Credit Rating of“ bb” to Mohandes Insurance Company. AM Best notes that ROE should be viewed in light of the recent high ...
We consider the environmental, social, and governance risk for Amcor to be low, despite the company's products being mostly made of plastic. Amcor pledges to develop all packaging to be recyclable by ...
President Donald Trump’s new executive order (EO) establishing a U.S. sovereign wealth fund has ignited discussions about Bitcoin’s (BTC) role in national ...
Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline. It came as the boss of the London-listed firm cheered an “excellent” performance ...